Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Sell
5
BIOX Quote, Financials, Valuation and Earnings
Last price:
$3.80
Seasonality move
:
-4.13%
Day range:
$3.79 - $3.91
52-week range:
$3.51 - $11.78
Dividend yield:
0%
P/E ratio:
312.90x
P/S ratio:
0.63x
P/B ratio:
0.74x
Volume:
41.5K
Avg. volume:
128.2K
1-year change:
-66.96%
Market cap:
$229.8M
Revenue:
$464.8M
EPS (TTM):
-$0.15
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Revenue | $172.4M | $206.7M | $328.5M | $419.4M | $464.8M | |
| Revenue Growth (YoY) | 7.51% | 19.93% | 58.91% | 27.7% | 10.82% | |
| Cost of Revenues | $93.4M | $116.8M | $203.7M | $240.6M | $282.4M | |
| Gross Profit | $78.9M | $89.9M | $124.8M | $178.9M | $182.4M | |
| Gross Profit Margin | 45.8% | 43.49% | 37.99% | 42.64% | 39.25% | |
| R&D Expenses | $4.2M | $5.6M | $6.9M | $15.3M | $17.2M | |
| Selling, General & Admin | $28.9M | $36.2M | $57.4M | $85.5M | $94.3M | |
| Other Inc / (Exp) | -$20.1M | -$6.2M | -$8.3M | -$11.4M | -$4.6M | |
| Operating Expenses | $40.8M | $51.9M | $84.5M | $124.5M | $140.9M | |
| Operating Income | $38.2M | $37.9M | $40.3M | $54.3M | $41.5M | |
| Net Interest Expenses | $11.7M | $21.2M | $17.9M | $23.8M | $26.9M | |
| EBT. Incl. Unusual Items | $6.4M | $10.5M | $14.1M | $19.1M | $10M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.2M | $14.4M | $18M | -$1.1M | $3.8M | |
| Net Income to Company | $4.2M | -$3.8M | -$3.9M | $20.2M | $6.3M | |
| Minority Interest in Earnings | -$877.5K | -$3M | -$3.3M | -$1.4M | -$3M | |
| Net Income to Common Excl Extra Items | $3.4M | -$6.9M | -$7.2M | $18.8M | $3.2M | |
| Basic EPS (Cont. Ops) | $0.09 | -$0.18 | -$0.17 | $0.30 | $0.05 | |
| Diluted EPS (Cont. Ops) | $0.09 | -$0.18 | -$0.17 | $0.30 | $0.05 | |
| Weighted Average Basic Share | $36.1M | $39.2M | $42.3M | $62.1M | $62.8M | |
| Weighted Average Diluted Share | $36.4M | $39.2M | $42.3M | $63.2M | $63.5M | |
| EBITDA | $30.6M | $35.7M | $38.2M | $59.7M | $55.5M | |
| EBIT | $25.8M | $29.5M | $29M | $40.3M | $34.2M | |
| Revenue (Reported) | $172.4M | $206.7M | $328.5M | $419.4M | $464.8M | |
| Operating Income (Reported) | $38.2M | $37.9M | $40.3M | $54.3M | $41.5M | |
| Operating Income (Adjusted) | $25.8M | $29.5M | $29M | $40.3M | $34.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $35.5M | $68.2M | $93M | $84M | $59.6M | |
| Revenue Growth (YoY) | 38.18% | 92% | 36.28% | -9.62% | -29.09% | |
| Cost of Revenues | $20.2M | $44.6M | $36.6M | $41.6M | $36.1M | |
| Gross Profit | $15.3M | $23.7M | $56.4M | $42.5M | $23.5M | |
| Gross Profit Margin | 43.11% | 34.68% | 60.61% | 50.55% | 39.39% | |
| R&D Expenses | $1.4M | $1.8M | $3.9M | $3.6M | $3.7M | |
| Selling, General & Admin | $10.2M | $18M | $24M | $21M | $21M | |
| Other Inc / (Exp) | $906.2K | -$204K | $378.2K | $3.6M | $6.5M | |
| Operating Expenses | $11.5M | $21.3M | $26.9M | $30M | $29.4M | |
| Operating Income | $3.9M | $2.4M | $29.5M | $12.5M | -$5.9M | |
| Net Interest Expenses | $5M | $4.8M | $7.6M | $7.2M | $6.1M | |
| EBT. Incl. Unusual Items | -$233.8K | -$2.6M | $22.3M | $8.8M | -$5.6M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $390.7K | $4.3M | -$5.2M | -$955.8K | -$4M | |
| Net Income to Company | -$624.5K | -$7M | $27.5M | $9.8M | -$1.6M | |
| Minority Interest in Earnings | -$556K | $490.2K | $667.4K | -$520.1K | $287.1K | |
| Net Income to Common Excl Extra Items | -$1.2M | -$6.5M | $28.1M | $9.3M | -$1.3M | |
| Basic EPS (Cont. Ops) | -$0.03 | -$0.16 | $0.45 | $0.15 | -$0.02 | |
| Diluted EPS (Cont. Ops) | -$0.03 | -$0.16 | $0.45 | $0.14 | -$0.02 | |
| Weighted Average Basic Share | $38.8M | $41.1M | $62M | $62.8M | $62.8M | |
| Weighted Average Diluted Share | $38.8M | $41.1M | $63.1M | $66.8M | $62.8M | |
| EBITDA | $5.6M | $4.5M | $34.5M | $20.5M | $6.6M | |
| EBIT | $3.9M | $2.4M | $29.5M | $15.5M | $559.2K | |
| Revenue (Reported) | $35.5M | $68.2M | $93M | $84M | $59.6M | |
| Operating Income (Reported) | $3.9M | $2.4M | $29.5M | $12.5M | -$5.9M | |
| Operating Income (Adjusted) | $3.9M | $2.4M | $29.5M | $15.5M | $559.2K | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $173.8M | $308M | $415.9M | $445.6M | $383.3M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $93.4M | $186.2M | $239.5M | $271.2M | $231.8M | |
| Gross Profit | $80.3M | $121.8M | $176.4M | $174.4M | $151.5M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $4.4M | $6.7M | $13.5M | $16M | $17.6M | |
| Selling, General & Admin | $30.5M | $60.4M | $94.8M | $93.2M | $88.3M | |
| Other Inc / (Exp) | -$19M | $6.9M | $199.3K | -$686.3K | -$6.6M | |
| Operating Expenses | $43.8M | $78.3M | $118.7M | $137.1M | $134.7M | |
| Operating Income | $36.5M | $43.5M | $57.7M | $37.3M | $16.7M | |
| Net Interest Expenses | $12M | $29.3M | $32.1M | $24.9M | $28.9M | |
| EBT. Incl. Unusual Items | $5.5M | $21.2M | $25.8M | $11.8M | -$18.8M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $7.6M | $19.2M | $7.4M | $6.2M | -$9.5M | |
| Net Income to Company | -$2.1M | $2M | $18.4M | $5.5M | -$9.3M | |
| Minority Interest in Earnings | -$3.2M | -$3.6M | -$3M | -$2.5M | $204.2K | |
| Net Income to Common Excl Extra Items | -$5.3M | -$1.6M | $15.5M | $3.1M | -$9.1M | |
| Basic EPS (Cont. Ops) | -$0.15 | -$0.03 | $0.22 | $0.01 | -$0.15 | |
| Diluted EPS (Cont. Ops) | -$0.15 | -$0.03 | $0.21 | $0.01 | -$0.15 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $29.8M | $49.9M | $67.9M | $53M | $30.8M | |
| EBIT | $24.4M | $42.2M | $49.4M | $33.9M | $6.9M | |
| Revenue (Reported) | $173.8M | $308M | $415.9M | $445.6M | $383.3M | |
| Operating Income (Reported) | $36.5M | $43.5M | $57.7M | $37.3M | $16.7M | |
| Operating Income (Adjusted) | $24.4M | $42.2M | $49.4M | $33.9M | $6.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Revenue | $125.6M | $226.9M | $314.4M | $340.5M | $259M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $67.6M | $137.4M | $173.5M | $204.7M | $154.2M | |
| Gross Profit | $58.1M | $89.5M | $140.9M | $135.8M | $104.8M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | $3.6M | $4.7M | $11.2M | $11.8M | $12.3M | |
| Selling, General & Admin | $29.5M | $48.9M | $76.7M | $71.7M | $65.7M | |
| Other Inc / (Exp) | -$6.3M | -$1.3M | -$291.8K | $3.9M | $1.5M | |
| Operating Expenses | $34.5M | $60.2M | $92.9M | $104.4M | $98.3M | |
| Operating Income | $23.6M | $29.4M | $48M | $31.3M | $6.5M | |
| Net Interest Expenses | $16.2M | $16.3M | $24.2M | $19.1M | $20.7M | |
| EBT. Incl. Unusual Items | $1M | $11.7M | $23.5M | $16.1M | -$12.7M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $6.2M | $11.1M | $507.9K | $7.8M | -$5.5M | |
| Net Income to Company | -$5.2M | $626.8K | $23M | $8.3M | -$7.2M | |
| Minority Interest in Earnings | -$2.3M | -$2.8M | -$2.5M | -$3.6M | -$345.8K | |
| Net Income to Common Excl Extra Items | -$7.5M | -$2.2M | $20.5M | $4.8M | -$7.5M | |
| Basic EPS (Cont. Ops) | -$0.21 | -$0.05 | $0.33 | $0.08 | -$0.12 | |
| Diluted EPS (Cont. Ops) | -$0.21 | -$0.06 | $0.32 | $0.07 | -$0.12 | |
| Weighted Average Basic Share | $113.1M | $123.3M | $184.2M | $188.5M | $188.5M | |
| Weighted Average Diluted Share | $114.2M | $125.9M | $186.5M | $193.5M | $188.8M | |
| EBITDA | $19.5M | $33.1M | $57.1M | $47.7M | $23.1M | |
| EBIT | $15.3M | $27.5M | $42.2M | $33.1M | $5.8M | |
| Revenue (Reported) | $125.6M | $226.9M | $314.4M | $340.5M | $259M | |
| Operating Income (Reported) | $23.6M | $29.4M | $48M | $31.3M | $6.5M | |
| Operating Income (Adjusted) | $15.3M | $27.5M | $42.2M | $33.1M | $5.8M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $42.5M | $36M | $33.5M | $48.1M | $44.5M | |
| Short Term Investments | $9M | $10.7M | $5.1M | $11.9M | $11.7M | |
| Accounts Receivable, Net | $73.5M | $88.8M | $111.8M | $158M | $207.3M | |
| Inventory | $30.3M | $63.4M | $126.1M | $140.6M | $126.2M | |
| Prepaid Expenses | $461.7K | $1.8M | $4.6M | $11M | $10.2M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $164.7M | $211.5M | $297.7M | $397.1M | $408.7M | |
| Property Plant And Equipment | $42.6M | $49.3M | $62.1M | $81.8M | $86.2M | |
| Long-Term Investments | $25M | $31.8M | $39.2M | $39.7M | $40.4M | |
| Goodwill | $25.5M | $28.8M | $36.1M | $112.2M | $112.3M | |
| Other Intangibles | $35.3M | $67.3M | $76.7M | $173.8M | $174.8M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $297.6M | $394.6M | $518.2M | $818.1M | $850.6M | |
| Accounts Payable | $53.8M | $69.3M | $124.4M | $146.3M | $161.9M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $63.6M | $76.8M | $71.3M | $107.6M | $136.7M | |
| Current Portion Of Capital Lease Obligations | $665.1K | $750.3K | $1.4M | $3.9M | $3.1M | |
| Other Current Liabilities | -- | -- | $3M | $1.4M | $4.8M | |
| Total Current Liabilities | $130.6M | $168M | $222.7M | $298.7M | $329.5M | |
| Long-Term Debt | $84.3M | $96.7M | $86.7M | $135.9M | $122.9M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $236.8M | $304.3M | $359.9M | $487.6M | $501.1M | |
| Common Stock | $3.6K | $4.2K | $4.6K | $6.5K | $6.5K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | $46.2M | $67.7M | $127.6M | $298.8M | $314.3M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $14.6M | $22.5M | $30.7M | $31.6M | $35.3M | |
| Total Equity | $60.7M | $90.3M | $158.3M | $330.5M | $349.6M | |
| Total Liabilities and Equity | $297.6M | $394.6M | $518.2M | $818.1M | $850.6M | |
| Cash and Short Terms | $51.6M | $46.8M | $38.6M | $60.1M | $56.2M | |
| Total Debt | $148M | $173.4M | $158M | $243.5M | $259.7M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $21.6M | $39M | $57.7M | $16.4M | $38.5M | |
| Short Term Investments | $27.6M | $2M | $12.9M | $16.5M | $889.4K | |
| Accounts Receivable, Net | $80.4M | $113.4M | $157.1M | $211.2M | $187.5M | |
| Inventory | $56.2M | $124.5M | $152.9M | $131.1M | $93.4M | |
| Prepaid Expenses | $1.6M | $4.5M | $10.5M | $6.8M | $6.5M | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | $193.8M | $297M | $421.2M | $407.2M | $338.2M | |
| Property Plant And Equipment | $43.9M | $52.4M | $79.7M | $87.3M | $92M | |
| Long-Term Investments | $29.6M | $36.6M | $40.3M | $42.8M | $39.6M | |
| Goodwill | $26.5M | $34.7M | $122.5M | $112.2M | $112.2M | |
| Other Intangibles | $61.1M | $75.7M | $174.3M | $174.5M | $181.8M | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | $361.2M | $503.6M | $846.8M | $836.1M | $798.2M | |
| Accounts Payable | $56.9M | $120.7M | $145.2M | $161.2M | $123.6M | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | $85.4M | $113.9M | $107.9M | $142.6M | $181.1M | |
| Current Portion Of Capital Lease Obligations | $507.4K | $838.8K | $3.1M | $3.5M | $5.6M | |
| Other Current Liabilities | $200K | $1.9M | $1.9M | $2.9M | $1.8M | |
| Total Current Liabilities | $157.1M | $255.1M | $302.8M | $333M | $332.3M | |
| Long-Term Debt | $97.9M | $91.1M | $142.2M | $100.2M | $75.7M | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $282.8M | $386.5M | $512.5M | $487.6M | $453.2M | |
| Common Stock | $4.1K | $4.2K | $6.4K | $6.5K | $6.5K | |
| Other Common Equity Adj | -- | -- | -- | -- | -- | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | $17.4M | $28.8M | $33.2M | $35.2M | $36.3M | |
| Total Equity | $78.4M | $117.1M | $334.3M | $348.5M | $345M | |
| Total Liabilities and Equity | $361.2M | $503.6M | $846.8M | $836.1M | $798.2M | |
| Cash and Short Terms | $49.2M | $41M | $70.7M | $32.8M | $39.3M | |
| Total Debt | $183.4M | $205M | $250.1M | $242.8M | $256.8M | |
| Period Ending | 2020-06-30 | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $4.2M | -$3.8M | -$3.9M | $20.2M | $6.3M | |
| Depreciation & Amoritzation | $4.7M | $6.3M | $9.2M | $19.4M | $21.3M | |
| Stock-Based Compensation | $3.4M | $1.7M | $1.4M | $3.4M | $14.1M | |
| Change in Accounts Receivable | -$26.6M | -$6.3M | -$32.3M | -$68.3M | -$51.6M | |
| Change in Inventories | -$5.3M | -$34.5M | -$55.3M | -$11.1M | $14.2M | |
| Cash From Operations | $9.3M | -$6.2M | -$17.5M | $2.6M | $41.7M | |
| Capital Expenditures | $4.5M | $13.9M | $9M | $22.6M | $22.8M | |
| Cash Acquisitions | -- | $253.9K | -- | $4.4M | $37.5K | |
| Cash From Investing | -$7.8M | -$8.3M | $2.9M | -$25.7M | -$28.7M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $135.3M | $143.5M | $140.4M | $79.8M | $135.8M | |
| Long-Term Debt Repaid | -$101.8M | -$117.3M | -$111.7M | -$20.6M | -$117.5M | |
| Repurchase of Common Stock | -$30.9K | -$3.5M | -- | -$3M | -$734.4K | |
| Other Financing Activities | $2.3M | -$1.4M | -$905K | -$5.2M | -$2.9M | |
| Cash From Financing | $33.5M | $7.4M | $14.8M | $33M | -$10.1M | |
| Beginning Cash (CF) | $3.5M | $42.5M | $36M | $33.5M | $48.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $35M | -$7.2M | $211.2K | $9.8M | $2.9M | |
| Ending Cash (CF) | $42.5M | $36M | $33.5M | $48.1M | $44.5M | |
| Levered Free Cash Flow | $4.8M | -$20.1M | -$26.5M | -$20M | $18.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$624.5K | -$7M | $27.5M | $9.8M | -$1.6M | |
| Depreciation & Amoritzation | $1.8M | $2.1M | $5M | $4.9M | $6.1M | |
| Stock-Based Compensation | $319K | $260.1K | $617.9K | $3M | $1M | |
| Change in Accounts Receivable | $15M | $13M | $16.7M | -$16M | $30.9M | |
| Change in Inventories | -$16.8M | -$15.5M | $4.1M | -$6.1M | $13.5M | |
| Cash From Operations | -$3.9M | $7.8M | $2.2M | -$17.4M | $23.3M | |
| Capital Expenditures | $6.7M | $2.5M | $6.1M | $6M | $3.2M | |
| Cash Acquisitions | -$101.9K | -- | -- | -- | -- | |
| Cash From Investing | -$11.6M | $318.6K | -$3.3M | -$1.4M | -$2.5M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $43.4M | $29.2M | $44M | $69.9M | $56M | |
| Long-Term Debt Repaid | -$23.6M | -$34.2M | -$49.9M | -$53.9M | -$64.6M | |
| Repurchase of Common Stock | -$2.7M | -- | -$222.4K | -- | -- | |
| Other Financing Activities | $1.3M | $477.6K | -$1.4M | -$535K | $49.7K | |
| Cash From Financing | $17.3M | -$4.5M | -$10.7M | $10.9M | -$12.7M | |
| Beginning Cash (CF) | $19.1M | $36.4M | $68.6M | $24.4M | $29.2M | |
| Foreign Exchange Rate Adjustment | $1.5M | $2.3M | $946.6K | -$167.9K | $1.1M | |
| Additions / Reductions | $1.8M | $3.5M | -$11.8M | -$7.9M | $8.2M | |
| Ending Cash (CF) | $21.6M | $39M | $57.7M | $16.4M | $38.5M | |
| Levered Free Cash Flow | -$10.6M | $5.3M | -$3.9M | -$23.4M | $20.2M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$2.1M | $2M | $18.4M | $5.5M | -$9.3M | |
| Depreciation & Amoritzation | $5.3M | $7.7M | $18.5M | $19.1M | $23.9M | |
| Stock-Based Compensation | $1.8M | $1.8M | $3M | $12.2M | $6M | |
| Change in Accounts Receivable | -$26.1M | -$19.1M | -$58.9M | -$66.5M | $7.3M | |
| Change in Inventories | -$32.6M | -$55.2M | -$24M | $15.9M | $39.4M | |
| Cash From Operations | -$23.8M | $9.3M | $5.7M | $10M | $46.4M | |
| Capital Expenditures | $12.7M | $10.3M | $18M | $23.3M | $18.5M | |
| Cash Acquisitions | -$101.9K | $355.8K | $4.4M | -- | $37.5K | |
| Cash From Investing | -$29.2M | $19.8M | -$23.9M | -$31.7M | -$7.9M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $143.1M | $138.3M | $212.2M | $38.7M | $136.1M | |
| Long-Term Debt Repaid | -$112.2M | -$131.5M | -$148.6M | -$25.8M | -$127M | |
| Repurchase of Common Stock | -$2.7M | -$821.4K | -$2.5M | -$1.2M | -$926.9K | |
| Other Financing Activities | $668.1K | -$3M | -$4M | -$1.7M | -$3.2M | |
| Cash From Financing | $22.8M | -$8.9M | $31.2M | -$12.1M | -$19.7M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$30.3M | $20.2M | $13M | -$33.8M | $18.8M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -$36.5M | -$1.1M | -$12.3M | -$13.3M | $27.9M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -$5.2M | $626.8K | $23M | $8.3M | -$7.2M | |
| Depreciation & Amoritzation | $4.2M | $5.7M | $15M | $14.7M | $17.3M | |
| Stock-Based Compensation | $955.5K | $1.1M | $2.7M | $11.5M | $3.4M | |
| Change in Accounts Receivable | -$13.6M | -$26.3M | -$53M | -$51.2M | $7.8M | |
| Change in Inventories | -$30M | -$50.7M | -$19.4M | $7.6M | $32.8M | |
| Cash From Operations | -$27.6M | -$12.1M | $11.1M | $18.5M | $23.1M | |
| Capital Expenditures | $10.6M | $7M | $16M | $16.7M | $12.4M | |
| Cash Acquisitions | -$101.9K | -- | $4.4M | -- | -- | |
| Cash From Investing | -$23.8M | $4.3M | -$22.5M | -$28.4M | -$7.6M | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $114.3M | $109.1M | $180.8M | $139.8M | $140.1M | |
| Long-Term Debt Repaid | -$79.2M | -$93.5M | -$130.4M | -$135.6M | -$145.1M | |
| Repurchase of Common Stock | -$2.7M | -- | -$2.5M | -$734.4K | -$926.9K | |
| Other Financing Activities | -$742.7K | -$2.4M | -$5.5M | -$2M | -$2.3M | |
| Cash From Financing | $29.5M | $13.2M | $29.6M | -$15.4M | -$25M | |
| Beginning Cash (CF) | $76.3M | $109M | $149.4M | $100.9M | $105.9M | |
| Foreign Exchange Rate Adjustment | $3.4M | $4.3M | $6.1M | -$6.4M | $3.5M | |
| Additions / Reductions | -$21.9M | $5.4M | $18.2M | -$25.4M | -$9.5M | |
| Ending Cash (CF) | $70.7M | $112M | $173.7M | $69.1M | $99.9M | |
| Levered Free Cash Flow | -$38.2M | -$19.1M | -$4.9M | $1.7M | $10.7M | |
Get BIOX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
BIOX
Sector
P/E ratio
312.90x
16.29x
PEG ratio
--
0.00x
P/B ratio
0.74x
1.42x
Price / LTM sales
0.63x
1.42x
Growth Metrics
BIOX
Sector
Revenue growth
-29.09%
1.07%
Earnings growth
35.29%
--
Revenue (5-year growth)
23.73%
3.71%
Earnings forecast
$0.10
$0.04
Profitability
BIOX
Sector
Profitability FY 2024
$182.4M
--
Return on invested capital
-1.5%
1.75%
Return on assets
-1.09%
1.06%
Return on equity
-2.61%
2.52%
Earnings Date
Last Earnings Date
May
21
Next Earnings Date
Sep
10
Estimated Next Earnings Date
Aug
20
Balance Sheet
BIOX
Sector
Total cash
$39.3M
$2.4M
Short term investments
$11.7M
$326.7K
Total assets
$850.6M
$21.1M
Long term debt
$256.8M
$74M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will FCX Benefit From Tariffs?
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Can Levi Stock Double?
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Stock Ideas
Buy
70
Is NVDA Stock a Buy?
Market Cap: $4.2T
P/E Ratio: 58x
Buy
62
Is MSFT Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 43x
Sell
40
Is AAPL Stock a Buy?
Market Cap: $3.1T
P/E Ratio: 35x
Alerts
Buy
82
SBET alert for Jul 17
SharpLink Gaming [SBET] is down 2.6% over the past day.
Buy
89
EXOD alert for Jul 17
Exodus Movement [EXOD] is down 4.14% over the past day.
Buy
60
U alert for Jul 17
Unity Software [U] is up 7.51% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
